XML 7 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Director and Executive Officer Trading Plans

 

In the quarter ended June 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or any non-Rule 10b5-1 trading arrangement for the purchase or sale of our securities, within the meaning of Item 408 of Regulation S-K, except as follows:


On June 12, 2025, Dr. Huiwen Yao, the Company’s Executive Vice President, Chief Technology Officer, entered into a Rule 10b5-1 sales plan (the “Yao 10b5-1 Sales Plan”) intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act for the sale of up to 160,000 shares of the Company’s Class A Common Stock. The Yao 10b5-1 Sales Plan will remain in effect until the earlier of (1) September 16, 2026, (2) the date on which all trades set forth in the Yao 10b5-1 Sales Plan have been executed, or (3) such time as the Yao 10b5-1 Sales Plan is otherwise terminated according to its terms.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Dr. Huiwen Yao [Member]  
Trading Arrangements, by Individual  
Name Dr. Huiwen Yao
Title Executive Vice President, Chief Technology Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 12, 2025
Expiration Date September 16, 2026
Arrangement Duration 461 days
Aggregate Available 160,000